Skip to content
Recall Observatory FDA recall evidence

Drug product

TRIESENCE, 8mg/2.0mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070

D-0226-2015

October 06, 2014

Class II

Product summary

Firm
Oregon Compounding Centers, Inc. dba Creative Compounds
Event
Event 69519
Status
Terminated
Classification
Class II
Quantity
2 syringes
Official record key
drug-enforcement:D-0226-2015

Official wording

Reason: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information: Lot #: 20140909@6, discard date: 10/24/2014

Distribution pattern: Oregon, Washington

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Sterility